ClinicalTrials.gov
public full text
Public Domain
Triferic IRIDA (Iron-Refractory Iron-Deficiency Anemia) Protocol
The main purpose is to determine whether Triferic, administered orally with Shohl's solution, is safe and effective for the treatment of iron-refractory iron-deficiency anemia (IRIDA).
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- A Retrospective Study to Assess the Clinical Efficacy and Safety of Trientine in Wilson's Disease Patients#1059419
- A Phase 1 Study to Assess the Effects in the Body of a Single Dose of Trientine Dihydrochloride in Wilson's Disease Patients#1074760
- Assessment of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Various Formulations and Doses of PWT-143#901860
- Thyroid Function , HbA1c in Relation to Ferritin Level in Adullt Patient e B Thalassemia#903098
- AC-OLE-01-VA Tolerability Study in Healthy Participants Under Different Dosing Conditions#1151053
Record · ID 1072901
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive